Population pharmacokinetics and dosing simulations of cefuroxime in critically ill patients: non-standard dosing approaches are required to achieve therapeutic exposures
- Author
- Mieke Carlier (UGent) , MICHAEL NOE (UGent) , Jason A Roberts, Veronique Stove (UGent) , Alain Verstraete (UGent) , Jeffrey Lipman and Jan De Waele (UGent)
- Organization
- Abstract
- Objectives: To investigate the population pharmacokinetics of cefuroxime in critically ill patients. Methods: In this observational pharmacokinetic study, multiple blood samples were taken over one dosing interval of intravenous cefuroxime. Blood samples were analysed using a validated ultra HPLC tandem mass spectrometry technique. Population pharmacokinetic analysis and dosing simulations were performed using non-linear mixed-effects modelling. Results: One hundred and sixty blood samples were collected from 20 patients. CLCR ranged between 10 and 304 mL/min. A two-compartment model with between-subject variability on CL, V of the central compartment and V of the peripheral compartment described the data adequately. Twenty-four hour urinary CLCR was supported as a descriptor of drug CL. The population model for CLwas CL u1xCLCR/100, where u1 is the typical cefuroxime CL in the population, which is 9.0 L/h. The mean V was 22.5 L. Dosing simulations showed failure to achieve the pharmacokinetic/pharmacodynamic target of 65% fT. MIC for an MIC of 8 mg/L with standard dosing regimens for patients with CLCR = 50 mL/min. Conclusions: Administration of standard doses by intermittent bolus is likely to result in underdosing for many critically ill patients. Continuous infusion of higher than normal doses after a loading dose is more likely to achieve pharmacokinetic/pharmacodynamic targets. However, even continuous infusion of high doses (up to 9 g per day) does not guarantee adequate levels for all patients with a CLCR of = 300 mL/min if the MIC is 8 mg/L.
- Keywords
- cephalosporins, beta-lactams, antibiotics, PK/PD, critical care medicine, ICUs, AUGMENTED RENAL CLEARANCE, BETA-LACTAM ANTIBIOTICS, SEPTIC SHOCK, MEROPENEM, CEFEPIME, CEFTAZIDIME, INFECTIONS, PNEUMONIA, SEPSIS, MODEL
Downloads
-
(...).pdf
- full text
- |
- UGent only
- |
- |
- 277.46 KB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-5742388
- MLA
- Carlier, Mieke, et al. “Population Pharmacokinetics and Dosing Simulations of Cefuroxime in Critically Ill Patients: Non-Standard Dosing Approaches Are Required to Achieve Therapeutic Exposures.” JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, vol. 69, no. 10, 2014, pp. 2797–803, doi:10.1093/jac/dku195.
- APA
- Carlier, M., NOE, M., Roberts, J. A., Stove, V., Verstraete, A., Lipman, J., & De Waele, J. (2014). Population pharmacokinetics and dosing simulations of cefuroxime in critically ill patients: non-standard dosing approaches are required to achieve therapeutic exposures. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 69(10), 2797–2803. https://doi.org/10.1093/jac/dku195
- Chicago author-date
- Carlier, Mieke, MICHAEL NOE, Jason A Roberts, Veronique Stove, Alain Verstraete, Jeffrey Lipman, and Jan De Waele. 2014. “Population Pharmacokinetics and Dosing Simulations of Cefuroxime in Critically Ill Patients: Non-Standard Dosing Approaches Are Required to Achieve Therapeutic Exposures.” JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 69 (10): 2797–2803. https://doi.org/10.1093/jac/dku195.
- Chicago author-date (all authors)
- Carlier, Mieke, MICHAEL NOE, Jason A Roberts, Veronique Stove, Alain Verstraete, Jeffrey Lipman, and Jan De Waele. 2014. “Population Pharmacokinetics and Dosing Simulations of Cefuroxime in Critically Ill Patients: Non-Standard Dosing Approaches Are Required to Achieve Therapeutic Exposures.” JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 69 (10): 2797–2803. doi:10.1093/jac/dku195.
- Vancouver
- 1.Carlier M, NOE M, Roberts JA, Stove V, Verstraete A, Lipman J, et al. Population pharmacokinetics and dosing simulations of cefuroxime in critically ill patients: non-standard dosing approaches are required to achieve therapeutic exposures. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2014;69(10):2797–803.
- IEEE
- [1]M. Carlier et al., “Population pharmacokinetics and dosing simulations of cefuroxime in critically ill patients: non-standard dosing approaches are required to achieve therapeutic exposures,” JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, vol. 69, no. 10, pp. 2797–2803, 2014.
@article{5742388, abstract = {{Objectives: To investigate the population pharmacokinetics of cefuroxime in critically ill patients. Methods: In this observational pharmacokinetic study, multiple blood samples were taken over one dosing interval of intravenous cefuroxime. Blood samples were analysed using a validated ultra HPLC tandem mass spectrometry technique. Population pharmacokinetic analysis and dosing simulations were performed using non-linear mixed-effects modelling. Results: One hundred and sixty blood samples were collected from 20 patients. CLCR ranged between 10 and 304 mL/min. A two-compartment model with between-subject variability on CL, V of the central compartment and V of the peripheral compartment described the data adequately. Twenty-four hour urinary CLCR was supported as a descriptor of drug CL. The population model for CLwas CL u1xCLCR/100, where u1 is the typical cefuroxime CL in the population, which is 9.0 L/h. The mean V was 22.5 L. Dosing simulations showed failure to achieve the pharmacokinetic/pharmacodynamic target of 65% fT. MIC for an MIC of 8 mg/L with standard dosing regimens for patients with CLCR = 50 mL/min. Conclusions: Administration of standard doses by intermittent bolus is likely to result in underdosing for many critically ill patients. Continuous infusion of higher than normal doses after a loading dose is more likely to achieve pharmacokinetic/pharmacodynamic targets. However, even continuous infusion of high doses (up to 9 g per day) does not guarantee adequate levels for all patients with a CLCR of = 300 mL/min if the MIC is 8 mg/L.}}, author = {{Carlier, Mieke and NOE, MICHAEL and Roberts, Jason A and Stove, Veronique and Verstraete, Alain and Lipman, Jeffrey and De Waele, Jan}}, issn = {{0305-7453}}, journal = {{JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY}}, keywords = {{cephalosporins,beta-lactams,antibiotics,PK/PD,critical care medicine,ICUs,AUGMENTED RENAL CLEARANCE,BETA-LACTAM ANTIBIOTICS,SEPTIC SHOCK,MEROPENEM,CEFEPIME,CEFTAZIDIME,INFECTIONS,PNEUMONIA,SEPSIS,MODEL}}, language = {{eng}}, number = {{10}}, pages = {{2797--2803}}, title = {{Population pharmacokinetics and dosing simulations of cefuroxime in critically ill patients: non-standard dosing approaches are required to achieve therapeutic exposures}}, url = {{http://doi.org/10.1093/jac/dku195}}, volume = {{69}}, year = {{2014}}, }
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: